Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cadence Pharmaceuticals history
Cadence Pharmaceuticals company history timeline
Recognizing the pressing need to serve the growing medical device market in new and unique ways, Specialty Blades created IncisionTech in 2005 with a new mission - to enable better patient outcomes through innovative incision technologies.
In January 2008, Specialty Blades, Inc. and its medical device division IncisionTech completed the acquisition of Popper and Sons, Inc.
In January of 2011, the three divisions of Cadence (Cadence Science, Incision Tech and Specialty Blades) were combined to create a truly unique partner for the healthcare and life science markets.
Cadence began sales of the drug in January 2011.
In August of 2014, Cadence acquired three operating business units of Plainfield Precision Holdings.
On May 21, 2018, Kohlberg & Company, a leading private equity firm based in Mount Kisco, New York, acquired Cadence.
On May 1, 2019, Cadence acquired the assets of Arcor Laser Services, LLC. Arcor is a leader in precision laser welding, cutting, machining, marking, and drilling, as well as turnkey systems integration.
15, 2019 Biotech Pink shoes and a lab jacket: Finding your way as a female scientist Nov.
Now, the company says job cuts are a result of “economic challenges” and a drop in government funding.June 29, 2022
Growth & DevelopmentFor subscribers Torrey Pines research campus cleared for Salk-inspired remodel Pre-leased ahead of construction, One Alexandria Square is intended as the gateway to San Diego’s premier life science corridor.June 23, 2022
Business San Diego’s Veyo, which brought an Uber model to health care transportation, is being acquired by rival MTM Non-emergency transit broker Medical Transportation Management expects acquisition of Veyo to boost its annual revenue to $1 billionJune 8, 2022
San Diego speakeasy Raised by Wolves lands on best bars list for North America June 10, 2022
Rate how well Cadence Pharmaceuticals lives up to its initial vision.
Cadence Pharmaceuticals jobs
Do you work at Cadence Pharmaceuticals?
Does Cadence Pharmaceuticals communicate its history to new hires?
Cadence Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Santarus | 1996 | $218.0M | 290 | - |
| Arbor Pharmaceuticals | 2006 | $175.0M | 157 | - |
| Eagle Pharmaceuticals | 2007 | $316.6M | 96 | 3 |
| Eton Pharmaceuticals | 2017 | $959,000 | 10 | - |
| Anthera Pharmaceuticals | 2004 | $1.0M | 21 | - |
| Tapestry Pharmaceuticals, Inc. | - | $6.1M | 38 | - |
| Anacor Pharmaceutical | 2000 | $82.4M | 100 | - |
| Tonix Pharmaceuticals | 2007 | $12.7M | 26 | 14 |
| William Stilley | 2010 | $200,000 | 2 | - |
| Dova Pharmaceuticals | 2016 | $10.4M | 115 | - |
Cadence Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of Cadence Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cadence Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cadence Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cadence Pharmaceuticals. The data presented on this page does not represent the view of Cadence Pharmaceuticals and its employees or that of Zippia.
Cadence Pharmaceuticals may also be known as or be related to CADENCE PHARMACEUTICALS INC and Cadence Pharmaceuticals.